📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Diabeloop

1.1 - Company Overview

Diabeloop Logo

Diabeloop

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of automated insulin delivery and diabetes management solutions, developing closed-loop systems to automate treatment of type 1 diabetes, including DBLG1, an algorithm-driven system; DBL-hu for highly unstable type 1 diabetes; and DBL-4pen, a smartphone app with an auto-learning algorithm linked to a connected insulin pen and CGM.

Products and services

  • DBLG1 System: Medical-grade automated insulin delivery product for type 1 diabetes that uses an algorithm to dynamically adjust insulin levels for improved glycemic management
  • DBL-4pen: Auto-learning smartphone application that integrates a connected insulin pen and continuous glucose monitor (CGM) to inform dosing decisions and streamline daily diabetes management
  • DBL-hu: Custom-engineered automated insulin delivery system specifically architected to manage highly unstable type 1 diabetes by adjusting insulin administration to stabilize difficult glycemic variability

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Diabeloop

Poxel Logo

Poxel

HQ: France Website
  • Description: Provider of biopharmaceutical products for metabolic diseases, focusing on type 2 diabetes and NASH. Portfolio includes TWYMEEG (Imeglimin), approved in Japan for type 2 diabetes, targeting mitochondrial dysfunction; PXL065, a deuterium-stabilized R-pioglitazone for NASH with Phase 2 primary endpoint met; and PXL770, a direct AMPK activator for rare diseases including NASH and ALD.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Poxel company profile →
Generex Logo

Generex

HQ: United States Website
  • Description: Provider of drug delivery systems and technologies for metabolic and immunological diseases, developing and commercializing these offerings.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Generex company profile →
Lifecare Logo

Lifecare

HQ: Norway Website
  • Description: Provider of miniaturized, implantable glucose sensors and nano biosensing solutions. Offerings include Sencell, a real-time glucose sensor measuring osmotic pressure, lasting at least six months and transmitting data wirelessly to smart devices; NanoBioSensors for high-resolution diagnostics in live tissue; and Lifecare Veterinary for continuous animal glucose monitoring.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lifecare company profile →
Intarcia Logo

Intarcia

HQ: United States Website
  • Description: Provider of long-term therapies for chronic diseases, offering the MEDICITM Drug Delivery System for twice-yearly subcutaneous osmotic implants, ITCA 650 (twice-yearly exenatide implant) for type 2 diabetes, and an Ionic Liquid Platform converting injectable biologics and peptides into oral therapies; pipeline includes i2o-105s (long-acting GLP-1 receptor agonist), i2o-107 (long-acting amylin), and i2o-110 (dual agonist) for type 2 diabetes, obesity, and NASH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intarcia company profile →
Rubin Medical Logo

Rubin Medical

HQ: Sweden Website
  • Description: Provider of diabetes aids for the public and healthcare sectors as a pharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rubin Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Diabeloop

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Diabeloop

2.2 - Growth funds investing in similar companies to Diabeloop

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Diabeloop

4.2 - Public trading comparable groups for Diabeloop

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Diabeloop

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Diabeloop

What does Diabeloop do?

Diabeloop is a provider of automated insulin delivery and diabetes management solutions, developing closed-loop systems to automate treatment of type 1 diabetes, including DBLG1, an algorithm-driven system; DBL-hu for highly unstable type 1 diabetes; and DBL-4pen, a smartphone app with an auto-learning algorithm linked to a connected insulin pen and CGM.

Who are Diabeloop's competitors?

Diabeloop's competitors and similar companies include Poxel, Generex, Lifecare, Intarcia, and Rubin Medical.

Where is Diabeloop headquartered?

Diabeloop is headquartered in France.

How many employees does Diabeloop have?

Diabeloop has 1,000 employees 🔒.

When was Diabeloop founded?

Diabeloop was founded in 2010 🔒.

What sector and industry vertical is Diabeloop in?

Diabeloop is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Diabeloop

Who are the top strategic acquirers in Diabeloop's sector and industry

Top strategic M&A buyers and acquirers in Diabeloop's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Diabeloop?

Top strategic M&A buyers groups and sectors for Diabeloop include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Diabeloop's sector and industry vertical

Which are the top PE firms investing in Diabeloop's sector and industry vertical?

Top PE firms investing in Diabeloop's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Diabeloop's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Diabeloop's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Diabeloop's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Diabeloop include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Diabeloop's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Diabeloop?

The key public trading comparables and valuation benchmarks for Diabeloop include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Diabeloop for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Diabeloop with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Diabeloop's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Diabeloop with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Diabeloop's' sector and industry vertical?

Access recent funding rounds and capital raises in Diabeloop's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Diabeloop